Investec acted as exclusive financial advisor to IntiQuan on the sale to ProductLife Group (PLG)<\/strong><\/p>\n\n\n\n PLG is a global leader in regulatory, scientific, compliance, and digital transformation consulting services for the life sciences industry backed by private equity investors Oakley Capital and 21 Invest. Founded in Switzerland in 2015 by Dr. Henning Schmidt, IntiQuan has rapidly established itself as a trusted provider of cutting-edge pharmacometric and statistical modelling & simulation services. The acquisition expands PLG\u2019s portfolio of specialized solutions that support biopharmaceutical companies with drug development, adding a key set of capabilities focused on significantly reducing development risk, costs and timelines and enhancing patient safety through advanced dose-response analyses and predictive safety profiling.<\/p>\n\n\n\n With the addition of IntiQuan, PLG is now in a position to offer customers cutting-edge pharmacometrics services that include strategic consulting, pharmacokinetics\/pharmacodynamics (PK\/PD), population pharmacokinetics (popPK), and biosimulation services. IntiQuan is renowned for its track record of translating complex data into actionable insights across a range of therapeutic areas and modalities from pre-clinical to Phase IV. Its team of scientific experts leverages advanced mathematical modeling and simulation techniques to inform clinical study design as well as analyze and predict trial outcomes.<\/p>\n\n\n\n This acquisition represents the next step in PLG\u2019s strategy to create a fully integrated global platform. With further expansions planned across the US and European markets, PLG is well on its way to becoming a leading global provider of comprehensive drug development services.<\/p>\n\n\n\n The Investec team has advised the owners of IntiQuan throughout the entire M&A process to the successful closure of the transaction, including:<\/p>\n\n\n\n \u201cJoining forces with PLG is a pivotal moment for IntiQuan, providing multiple drivers for the continued success of our company. Investec played a key role in realizing this deal. Their international presence, deep industry knowledge and strong commitment were instrumental in navigating the complexities in the process and getting to a transaction with a globally active partner with strong strategic and cultural fit for IntiQuan. We could not have had a better M&A advisor throughout this critical journey.\u201d<\/em><\/p>\nDr. Henning Schmidt<\/strong>, founder of IntiQuan AG<\/cite><\/blockquote>\n","protected":false},"excerpt":{"rendered":" About the deal Investec acted as exclusive financial advisor to IntiQuan on the sale to ProductLife Group (PLG) PLG is…<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[26,31],"dealtype":[33],"clienttype":[34],"class_list":["post-47308","deals","type-deals","status-publish","hentry","sector-business-services","sector-healthcare","dealtype-sell-your-business","clienttype-founders-entrepreneurs"],"acf":[],"yoast_head":"\n
<\/p>\n\n\n\nWhat we did<\/h2>\n\n\n\n
\n
\n